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Transcranial direct current stimulation
combined with physical or cognitive
training in people with Parkinson’s disease:
a systematic review
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Abstract
Background: Pharmacologic therapy is the primary treatment used to manage Parkinson’s disease (PD) symptoms.
However, it becomes less effective with time and some symptoms do not respond to medication. Complementary
interventions are therefore required for PD. Recent studies have implemented transcranial direct current stimulation
(tDCS) in combination with other modalities of interventions, such as physical and cognitive training. Although the
combination of tDCS with physical and cognitive training seems promising, the existing studies present mixed
results. Therefore, a systematic review of the literature is necessary.
Aims: This systematic review aims to (i) assess the clinical effects of tDCS when applied in combination with
physical or cognitive therapies in people with PD and; (ii) analyze how specific details of the intervention protocols
may relate to findings.
Methods: The search strategy detailed the technique of stimulation, population and combined interventions (i.e.
cognitive and/or physical training). Only controlled studies were included.
Results: Seventeen of an initial yield of 408 studies satisfied the criteria. Studies involved small sample sizes. tDCS
protocols and characteristics of combined interventions varied. The reviewed studies suggest that synergistic effects
may be obtained for cognition, upper limb function, gait/mobility and posture when tDCS is combined with
cognitive and/or motor interventions in PD.
Conclusion: The reported results encourage further research to better understand the therapeutic utility of tDCS
and to inform optimal clinical use in PD. Future studies in this field should focus on determining optimal
stimulation parameters and intervention characteristics for maximal benefits in people with PD.
Keywords: Neurodegenerative disease, Movement disorders, Transcranial stimulation, Physical therapy, Cognition,
Rehabilitation
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Introduction
Parkinson’s disease (PD) is a neurodegenerative disorder
mainly characterized by the progressive loss of dopamin-
ergic neurons in the substantia nigra pars compacta.
This leads to excessive GABAergic (inhibitory) signaling
from the output nuclei of the basal ganglia to the thal-
amus and other subcortical structures [1, 2]. In turn, the
thalamus sends reduced excitatory signaling to many
cortical areas, leading to a broad cortical dysfunction in
PD [1, 2], which includes sensorimotor and cognitive
areas. PD is traditionally described as a movement dis-
order, including symptoms such as bradykinesia, resting
tremor, rigidity, postural instability and gait impairments
[3, 4]. Mood disorders (e.g. anxiety and depressive symp-
toms) and cognitive impairments (e.g. executive func-
tion, memory, etc.) are also common and disabling in
PD [5, 6]. Dopaminergic medication is the primary treat-
ment used to manage PD symptoms. However, it be-
comes less effective and side effects emerge with time,
such as dyskinesia, motor fluctuations and hallucination
[7, 8]. Additionally, cognitive impairments and postural
instability do not respond to dopaminergic medication
[9, 10]. Complementary interventions are therefore re-
quired for PD.
A growing body of evidence suggests that transcranial
direct current stimulation (tDCS), a low-cost method of
non-invasive brain stimulation, could potentially become
a clinical tool for PD in the near future [11–14]. tDCS
directs, through scalp electrodes, a constant low ampli-
tude electric current (generally between 1 and 2mA),
which has been shown to modulate excitability in both
cortical [15] and subcortical brain areas [16, 17]. Anodal
tDCS leads to increased neuronal excitability whereas
cathodal tDCS leads to reduced neuronal excitability
[15, 18]. tDCS can also modulate oxygen supply to cor-
tical and subcortical areas [19] and neuronal synapsis
strength [20], triggering plasticity processes. Of par-
ticular interest to its application in PD, anodal tDCS
increases extracellular dopamine levels in the striatum
[21] and inhibits GABAergic neurons [22, 23]. Recent
systematic reviews confirmed that, as a stand-alone
intervention, tDCS promotes benefits on motor func-
tion and to a lesser extent on cognition in people
with PD [12, 24].
Taking advantage of tDCS portability, researchers have
implemented tDCS in combination with other modalities
of complementary interventions, such as physical (i.e.
exercise, physiotherapy, etc.) [25] and cognitive training
[26, 27]. The idea is that such combinations would pro-
mote greater, synergistic effects than the interventions
applied separately [28, 29]. In this context, tDCS can be
applied concurrently or as a priming technique. It has
been argued that such applications may reinforce long-
term potentiation-like processes [30], promoting greater
retention of benefits from combined therapy [31]. Al-
though the combination of tDCS with physical and cog-
nitive training seems promising, the existing studies
present mixed results. Therefore, a systematic review of
the literature is necessary. This systematic review
assessed: (i) the clinical effects of tDCS when applied in
combination with physical or cognitive therapies in
people with PD and; (ii) how specific details of the inter-
vention protocols may relate to findings.
Methods
Search strategy
Two of the authors (VSB and NRC) created a search
strategy, which was approved by all authors, to identify
all potentially relevant studies. Table 1 shows the terms
and synonyms used to search papers in the databases in
the title, abstract or keywords. The search strategy in-
cluded three fields (connected with “AND”) with inde-
pendent search terms. Terms in the same field were
connected with the conjunction “OR”. The first search
field focused on the population (i.e. Parkinson’s disease).
The second search field comprised types of non-
pharmacologic treatments (i.e. motor/physical therapies,
rehabilitation, cognitive therapies, and exercises). The
third search field focused on tDCS. The search terms
were combined and explored with the medical subject
headings (MeSH) in different databases (Pubmed,
Scopus, Embase, Web of Science and PsycNET).
Table 1 Search terms used in each search field
Population Intervention Transcranial stimulation
TITLE-ABS-KEY’ TITLE-ABS-KEY’ TITLE-ABS-KEY’

















a indicates a wildcard; TITLE-ABS-KEY’ indicates a title, abstract and
keyword search
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Manuscripts identified through databases search were
downloaded to a reference manager software where du-
plicates were excluded. Two authors (VSB and NRC)
performed the initial screen by reviewing the titles and
abstracts and when necessary a third author (RV) made
the final decision. However, in cases that the eligibility
of the study was not clear by the information provided
in the title and abstract, a review of the full text was per-
formed. Additional sourced articles were acquired by
screening reference lists.
Inclusion and exclusion criteria
Articles were included if they investigated the effects
of tDCS combined with physical and/or cognitive
therapies on motor, cognitive, neuropsychiatric, qual-
ity of life, and others outcomes in people with PD
(only human participants). Only articles written in
English were considered for the review. Any open-
label studies, review papers, book chapters, commen-
taries, study protocols, or clinical trials registers were
excluded. Articles that analyzed the effects of tDCS as
a stand-alone intervention and those involving other
techniques of transcranial stimulation (e.g., transcra-
nial alternating current stimulation, transcranial mag-
netic stimulation, etc.) were also excluded to avoid
confusion with the reviewed topic.
Data extraction
Data were extracted by five reviewers (VSB, NRC, PNS,
DOS, LKBFD) and synthesized into a table format. Data
entry was confirmed by another reviewer (RV). Data in-
cluded authors, year of publication, groups and partici-
pants characteristics (number of participants, score of
Unified Parkinson’s Disease Rating Scale motor section
(UPDRS III), years since the diagnosis, levodopa equiva-
lent daily dosage), study design, tDCS protocol (current
stimulation, sham characteristics, electrode placement,
stimulation intensity and duration, electrode size and
number of sessions), therapy protocol (type, characteris-
tics, volume, intensity, duration, moment and number of
sessions), assessment (period; medication state and out-




The flow chart with information regarding the different
phases of the search and screening process is shown in
Fig. 1. The search strategy yielded 408 studies from pub-
lication databases. One hundred and sixty-four dupli-
cates were removed. After further review of title and
abstract, 20 articles were included by consensus of the
reviewers. After full text review, three studies were ex-
cluded, one because it did not involve people with PD
Full text articles 
assessed for eligibility 
(n = 20)
Articles included for 
review 
(n = 17)
Records Identified through 
database searching ( n = 408)
Embase n = 8, Web of Science n = 146, 
Pubmed n = 100, PsycNET n = 49, 
Scopus n = 105
Full text articles excluded (n = 3)
- involving other populations (n = 1)



























Fig. 1 Flowchart with screening process following the PRISMA guidelines
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[32], and two because they did not have control group
or sham condition [26, 27]. Table 2 shows the extracted
data regarding the methodological aspects of the studies
included in the present systematic review.
Participants
The sample size varied from 1 to 53 participants, with a
mean age between 56.67 and 79 years. The mean of the
UPDRS motor section (part III) score ranged from 10.9
to 47.7. The disease duration ranged from 4.4 to 9.4
years and Levodopa Equivalent Dose (LED) ranged from
251.56 to 912 mg/day.
Study design
Seven studies had cross-over design [25, 28, 34, 37,
39–41] and ten were controlled trials with parallel
arms. Three studies did not mention information re-
garding how or if experiments were blinded [37, 40,
42], three studies consisted of single-blind experi-
ments [28, 34, 36] and eleven studies consisted of
double-blind experiments. It is worth mentioning that
all the included studies randomly assigned partici-
pants into groups/conditions.
tDCS protocol
Polarity, current intensity, and number of sessions
Fifteen studies included anodal tDCS protocols targeting
a single brain region [28, 29, 31, 33–40, 42–45] whereas
two studies stimulated both hemispheres [25, 41].
Thirteen studies used 2mA [25, 29, 31, 33, 35–39, 41,
43–45], one study used 1.5 mA [42] and three studies
used 1 mA [28, 34, 40]. Seven studies used a single ses-
sion of tDCS protocols [25, 28, 34, 36, 37, 39, 41] and
ten studies applied multiple sessions of tDCS protocols,
varying between 2 and 16 sessions.
Electrode size and placement
Fifteen studies used 35–40 cm2 electrodes, one study
used 15 cm2 electrodes [36] and one study used 80 cm2
electrodes [39]. Anodal electrode was placed over the
dorsolateral prefrontal cortex (DLPFC) in six studies [29,
33, 36, 38, 42, 43], frontal polar area in one study [40]
and over motor areas (i.e., primary motor cortex (M1),
premotor cortex (PMC) and supplementary motor area
(SMA)) in ten studies [25, 28, 31, 34, 35, 37, 39, 41, 44,
45]. The reference electrode (cathode) was placed over
the contralateral supraorbital region in twelve studies
[28, 29, 31, 33–35, 37, 38, 43–45], over the ipsilateral
supraorbital region in one study [42], over the frontal
orbit in one study [39], over the inion in two studies [25,
41] and over the occipital area in one study [40].
Duration of the stimulation (active and sham)
Stimulation time for active protocols varied between 7.5
and 30min, with nine studies using 20-min sessions [28,
33, 34, 36–39, 42, 44]. Most of the studies used sham
protocols in which the current was delivered during the
initial period of the session (8 to 60 s) and then turned
off; ten studies reported that the current was delivered
during the initial 30 s [25, 28, 31, 35–41]. Two studies
reported that the current was turned on once again for
the last 10 s of the session [29, 43].
Combined interventions
tDCS protocols were combined with motor interventions
in thirteen studies [25, 28, 29, 31, 34–41, 45], cognitive
interventions in three studies [33, 42, 43] and motor-
cognitive intervention in one study [44].
Seven studies combined tDCS protocols with acute in-
terventions [25, 28, 34, 36, 37, 39, 41] and in all of them
tDCS was applied concurrently (not as a priming tech-
nique). Ten studies combined tDCS protocols with
chronic interventions [29, 31, 33, 35, 38, 40, 42–45]. Five
of the chronic studies applied tDCS as a priming tech-
nique [31, 35, 38, 42, 45] while five studies applied tDCS
during the combined intervention [29, 33, 40, 43, 44].
Chronic interventions varied between 3 and 5 sessions
per week (between 5 and 16 sessions in total), with total
duration (not only tDCS) between 15 and 60 min [29,
31, 33, 35, 38, 40, 42–45].
Assessment characteristics
Fifteen studies carried out pre- and post-assessments
[25, 29, 31, 33–35, 37, 38, 41, 42, 44, 45] and seven
chronic studies also included follow-up assessments after
4 [31, 35] or 12 weeks [29, 38, 42–44]. Twelve studies
assessed patients while ON medication [25, 28, 29, 34–37,
41–45], two studies while OFF medication [39, 40], one
study assessed patients in both ON and OFF states [31]
and two studies did not report medication state [33, 38].
Although the methods used for assessment varied in the
included studies, a few tests were repeated. The Timed Up
and Go test (TUG) was used in six studies [25, 29, 31, 35,
36, 44], the UPDRS motor section was used in seven stud-
ies [29, 33, 35, 39, 40, 43, 45], Parkinson’s Disease Quality
of Life Questionnaire-39 (PDQ-39) was used in four stud-
ies [29, 35, 42, 43] and Mini Mental State Examination
(MMSE) and Parkinson’s Disease – Cognitive Rating Scale
(PD-CRS) were used in three studies [29, 42, 43].
Effects of tDCS
Table 3 presents the main results regarding the effects of
tDCS when combined with motor and/or cognitive in-
terventions. Figure 2 summarizes the main findings of
the 17 included studies separately for gait/mobility, pos-
tural control, upper limb movements, other motor
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(n = number of participants;
mean ± standard deviations
(year); UPDRS III (score); PD










6. Electrode size (cm2)
7. Number of sessions
Intervention
1. Type (acute/chronic)
2. Characteristics (strength, gait,
cognition, etc)
3. Volume (only chronic); Intensity;
duration
4. Moment






- Cognitive Training + active
tDCS
(n = 12; 69.1 ± 7.6; NR; NR;
NR)
- Cognitive Training + sham
tDCS
(n = 12; 72.3 ± 4.1; NR; NR;
NR)












2. Computer-based cognitive training




A. Pre, post, and follow-up (16 weeks)
B. NR
C. Attention/executive skills (Written
coding test); memory (immediate
memory index and delayed memory
index); disease severity (UPDRS III)
Broeder
(2019) [28]
- tDCS + writing Parkinson
group
(n = 10; 63.2 ± 9.2; 17.5 range





2. Current applied for
the 30s








3. 3 bouts of writing several sequences
of letters (3 min) followed by execution





C. Number of upper limb freezing




- tDCS + writing Parkinson
group
(n = 10; 63.2 ± 9.2; 17.5 range













3. Writing of loops in different
patterns (continuous and alternating)
and sizes (0.6 and 1.0 cm) during 3
trials (2 min 24 s each) followed by
execution of the funnel task (5 trials of
1 min each); 20 min
4. During tDCS
5. 1 session
A. Pre, during, post (30 min after
training) and follow-up (1 week)
B. ON state
C. writing performance on tablet
(amplitude, velocity, coefficients of
variation); writing performance on
paper (mean writing size, writing
velocity and writing quality/Systematic
Screening of Handwriting Difficulties
test); motor cortex excitability – MEP,




- tDCS + gait training
(n = 11; 61.1 ± 9.1; 19 ± NR;
6.1 ± 3.8; 740.9 ± 924.3)
- Sham + gait training
(n = 11; 62 ± 16.7; 19.1 ± NR;
6.3 ± 3.7; 890.9 ± 836)
• Parallel, double-blind, ran-
domized controlled trial
1. Anodic











2. Visually cued gait training (Subjects
were instructed to walk at the step
length indicated by white strips (visual
cue) along a 6.5-m walkway)
3. 3 times a week; 24 min of active
training, with a 6 min interval (30 min
total)
4. After tDCS session
5. 10 sessions
A. Pre, post (48 h after training) and
follow-up (1 month)
B. ON and OFF state
C. Functional mobility (TUG); motor




- Cued gait training + tDCS
(CGT + tDCS)
(n = 11; 61.1 ± 9.1; 19.0 ± 4.9;
6.1 ± 3.8; 740.9 ± 924.3)
- Cued gait training + sham
(CGT + sham)
(n = 11; 62.0 ± 16.7; 17.6 ±
5.1; 6.3 ± 3.7; 890.9 ± 836.0)




2. The stimulator was











2. The gait training associated with
visual cues was aimed to improve
functional mobility
3. 3 days a week; NR; 30 min
4. After the tDCS
5. 10 sessions
A. Pre, post, and follow-up (1 month)
B. ON state
C. Functional mobility (TUG, 10-m walk
test); Cadence, stride length (video
camera); Motor Impairment (UPDRS III);
Bradykinesia (sum of scores on UPDRS
items 23–26 and UL-MT); Balance (BBS);
Quality of life (PDQ-39)
Criminger
(2018) [36]
tDCS (Sitting, Bike, Wii,
Sham)
1. Anodic
2. Current applied for
1. Acute
2. Bike/Wii (golf)
A. Post each session
B. ON state
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Table 2 Methodological characteristics of the studies included in the systematic review following the determination of the PICOS
terms (Continued)
(n = 16; 68.13 ± 9.76; 23.44 ±
9.73; 8.69 ± 9.76; NR)
• Cross-over, single-blind,
randomized controlled trial
30s (1 to 0 mA)






3. Bike: self-reported intensity level of
12–14 on the Borg Rating of Perceived
Exertion Scale, Wii: NR; 20 min
4. During tDCS
5. 1 session
C. Dual-task performance during walk-
ing (TUG and TUG with dual task






- treadmill + tDCS
- treadmill + sham
(n = 18; 56.67 ± 11.63;















3. 1 day a week; Individual velocity
obtained during overground walking
at the beginning of each experimental





A. Pre and post each session
B. ON state
C. Gait (Optogait, Microgait);
Neurophysiologic measurements:
Electromyography, Reciprocal Ia
Inhibition, H-reflex amplitude, MEP;
SICI, ICF (EMG and TMS)
Forogh
(2017) [38]
- tDCS + occupational
therapy
(n = 12; 61.33; NR; NR; NR)
- Sham + occupational
therapy
(n = 11; 64.11; NR; NR; NR)
• Parallel, double-blind, ran-
domized clinical trial.
1. Anodic










3. 4 days a week (2 week); NR; NR.
4. After tDCS
5. 8 sessions
A. Pre, post and follow-up (3 months)
B. NR





- tDCS + mirror visual
feedback
(n = 9; 71.33 ± 4.15; 13 ± 5.56;
6.44 ± 3.16; 324.00 ± 121.11)
- Sham + mirror visual
feedback (n = 9; 70.67 ±
3.85; 17.11 ± 6.10; 6.44 ±
3.28; 251.56 ± 157.63)
• Parallel, double-blind, ran-
domized clinical trial.
1. Anodic









2. Motor skill training using mirror
visual feedback
3. 4 sessions of 30 s of execution and
30 s of rest for 5 min each session;
observe the movements of the right
hand in a mirror that provided mirror
visual feedback of their performance in
the ball rotation task; 20 min.
4. During tDCS
5. 4 sessions (1 day)
A. Pre and post
B. OFF state
C. Upper limb motor function (Number
of ball rotations /video camera analysis,
peak acceleration/infrared cameras and
reflective markers, maximal pinching
force), and disease severity (UPDRS III).
Ishikuro
(2018) [40]
- Anodal tDCS + Physical
therapy
(n = 9; 77.5 ± 4.8; NR; 5.77 ±
2.03; NR)
- Cathodal tDCS + Physical
therapy






2. Current applied for
30s







2. Physical therapy for
upper extremities (stretching and
muscle strength exercise) while
sitting in a chair
3. 5 days a week; 15 min
4. During tDCS
5. 5 sessions for each condition.
A. Pre, post 1 (1 session), post 2 (3
sessions) and post 3 (5 sessions). Post
1 and post 2 performed only for the
STEF
B. OFF state
C. Disease severity (UPDRS III); Sensory-
motor functions (Fugl Meyer Assess-
ment set); Ability to pinch, grasp, and




- tDCS + Physical training
(n = 8; NR; NR; NR)
- tDCS without physical
training




2. The current (2 mA)
was turned off after
30 s







2. Gait initiation, stride





A. Pre and post
B. ON state
C. Gait
(TUG, 6-min walk, and video analysis);
Balance (Quantitative pull test, SwayS-




- Dance + tDCS
- Dance + sham





2. 2 mA for only 30s
and then turned off
3.Bilateral M1 and
PMC/ inion




2. Dance – tango
3. 2 music; 7 min 30 s
4. During tDCS
5. 2 sessions
A. Pre and post
B. ON state
C. Angular trunk movement during the
dancing (digitally-based angular-
velocity transducers); gait (Tinetti Gait
Index)
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Table 2 Methodological characteristics of the studies included in the systematic review following the determination of the PICOS
terms (Continued)
7. 2 sessions for each






(n = 5; 68.14 ± 8.69; NR;
5.29 ± 4.23; 295 ± 313.40
- Tailored Cognitive Training
(Tailored CT)
(n = 6; 65.57 ± 5.20; NR;
5.79 ± 4.97; 383 ± 178.62
- tDCS
(n = 7; 72 ± 6.45; NR; 5.50 ±
5.66; 573.29 ± 586.25
- Standard Cognitive
Training + tDCS (Standard
CT + tDCS)
(n = 7; 63.57 ± 15.68; NR;
6.79 ± 4.60; 350.71 ± 322.37
- Tailored Cognitive Training
+ tDCS (Tailored CT + tDCS)
(n = 7; 67.43 ± 6.37; NR;
4.43 ± 2.70; 464.29 ± 358.78
- Control Group (CG)
(n = 6; 72.29 ± 6.21; NR;












2. Cognitive training (Smartbrain Pro™):
Standard (Two predetermined activities
for each cognitive domain - memory,
attention/working memory, language,
executive function, visuospatial) or
Tailored (activities individualized to
participants baseline
neuropsychological test results).
3. 3 days a week; difficulty levels of
each activity were adjusted
individually; 45 min
4. Separated of tDCS session
5. 12 sessions




(executive function, attention -
working memory, memory, visuospatial
abilities, language, global cognitive,




- Physical therapy + tDCS
(n = 10; 69.0 ± 9.1; 27.8 ±
13.9; 7.1 ± 3.6; 524.6 ± 179.1)
- Physical therapy + sham
(n = 10; 69.1 ± 5.6; 27.6 ± 8.9;




2. 2 mA for only 10s
and then turned off
and turned on in the
last 10s
3. DLPFC contralateral









2. Focused on the core areas of motor
impairment in PD, such as the inability
to initiate movement, difficulties with
balance and gait control, falls, and
deficits in the pacing of rhythmic
movements.
3. 5 days a week; 25 min
4. During tDCS
5. 10 sessions
A. Pre, post, and follow-up (3 months)
B. ON state
C. Cognition (MMSE, PD-CRS, Digit
span, Cantab Paired Associated Learn-
ing, TMT, FAB, Semantic fluency, Can-
tab Reaction Time Index); clinical
evaluation (UPDRS-III, HY, BDI-II, PDQ-
39, RBDSQ); motor function (TUG, Four
Square Step Test, Standing Stork Test,
Sit and Reach Test)
Manenti
(2018) [43]
- tDCS + computerized
cognitive training (n = 11;
65.5 ± 6.4; 26 ± 10.3; 6.2 ±
3.9; 618.6 ± 304.4)
- Sham + computerized
cognitive training (n = 11;
63.8 ± 7.1; 22.7 ± 7.8; 7.6 ±




2. 2 mA for only 10s
and then turned off









2. BrainHQ (Posit Science) – exercise
focused on attention, memory, brain
speed, people skills, navigation and
intelligence. Five exercises of 5 min for
each session.
3. 5 days a week for 2 weeks; 25 min
4. During tDCS
5. 10 sessions
A. Pre, post and follow-up (3 months)
B. ON state
C. Clinical and disease severity (PDQ-
39, BIS-11, RBDSQ, Apathy Evaluation
Scale, UPDRS III, H&Y); Cognitive func-
tions (MMSE; PD-CRS, Digit span, Rey
Auditory Verbal Learning Test, Object
and action IPNP, TMT, FAB, phonemic




- Active tDCS + dual-task
gait training
(n = 8; 72 ± 4.9; 47.7 ± 7.5;
6.9 ± 4.4; 730 ± 341
- Sham + dual-task gait
training
(n = 8; 63 ± 11.0; 37.7 ± 9.8;
4.6 ± 3.9; 523 ± 398
• Parallel, double-blind, ran-
domized, sham-controlled
1. Anodic
2. Ramped up over





4. 20 min (In the first






2. Gait training + cognitive task




A. Pre, Post, and follow-up (12 weeks)
B. ON state
C. Gait, Gait + cognitive task
(GAITRite® and TUG); bradykinesia
(clinical test); visuomotor speed and
procedural learning (Serial Reaction
Time Task).
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symptoms, cognition, neuropsychiatric symptoms and
others (including quality of life, fatigue and sleep
disorders).
Gait and mobility
Two out of eight studies reported synergistic effects on
gait and mobility at post-test, including increases in gait
speed and stride length and improvement in the turn
phase of TUG [25, 41]. The other six studies assessing
gait reported similar findings for both active and sham
tDCS at post-test [29, 31, 35, 37, 44, 45]. Two of out five
studies observed synergistic effects on gait and mobility
at follow-up assessment [31, 35]. The other three studies
assessing gait and mobility reported similar findings for
both active and sham tDCS at follow-up test [29, 44, 45].
Postural control
Two out of four studies reported synergistic effects on
postural control at post-test, including reduced time
taken to recover balance following retropulsion and in-
creased trunk peak velocity during tango [25, 41]. The
other two studies assessing postural control reported
similar findings for both active and sham tDCS at post-
test and follow-up test [29, 35].
Upper limb movements and motor symptoms
The four studies assessing upper limb function observed
synergistic effects. Broeder et al. (2019) [28] observed
that active tDCS reduced the number of upper limb
freezing episodes during writing. Synergistic effects were
demonstrated for upper limb movement at post-test and
follow-up [34, 39, 40]. Five out of six studies assessing
motor symptoms and/or disease severity throughout
clinical test reported similar findings for both active and
sham tDCS at post-test and follow-up [33, 35, 39, 44,
45]. Only one study reported synergistic effects on dis-
ease severity at the post-test [40].
Cognition
Five out of six studies reported synergistic effects on
cognition at post-test, including increased number of
correct responses during the TUG with dual task, im-
proved executive function, attention, working memory,
verbal fluency and the total and frontal-subcortical
scores on PD-CRS [29, 40, 42–44]. The benefits offered
by the combined interventions on cognition were main-
tained at the follow-up test. On the other hand, Biundo
et al. (2015) [33] observed negative effects of tDCS on
cognition when combined with cognitive training. These
authors reported decrement performance for the active
tDCS compared to the sham group in attention/execu-
tive skills at post-test; additionally, only the sham group
improved delayed memory index at post-test. Interest-
ingly, Biundo et al. (2015) [33] observed a trend for
better performance in the active tDCS group com-
pared with the sham group in the story learning test
at follow-up.
Neuropsychiatric symptoms, fatigue, sleep disorders and
quality of life
Neuropsychiatric symptoms (i.e. depression [29]), sleep
disorders [38] and/or quality of life [29, 35, 42] were less
frequently assessed. Synergistic effects on neuropsychi-
atric symptoms (at post-test and follow-up) [43] and fa-
tigue (at post-test) [38] were reported by only one study.
Discussion
This review examined 17 studies that assessed the ef-
fects of tDCS when applied in combination with
physical or cognitive therapies in people with PD. In
summary, the included studies had appropriate design





(n = 18; 64.4 ± 7.8; 10,89 ± 4,
75; 7,9 ± 3,9; 849,1 ± 397,1)
- tDCS + physical therapy
(n = 17; 68.2 ± 9.8; 11,94 ± 4,
68; 9,4 ± 5,3; 829,0 ± 360,6)
- Sham + physical therapy
(n = 18; 62.7 ± 2.8; 11,17 ± 3,
97; 6,6 ± 3,6; 912,0 ± 472,9)
• Parallel, double-blind, ran-
domized controlled trial
1. Anodic









2. Joint range of motion and body
flexibility, strengthening leg muscles,
balance and gait training
3. 3 days per week; 30 min
4. After tDCS
5. 6 sessions
A. Pre, Post, and follow-up (2 and 6
weeks)
B. ON state
C. Gait (The Gait & Motion Analysis);
Disease severity (UPDRS)
aLED was calculated according to Tomlinson et al. (2010) [46]; PD = Parkinson’s disease; UPDRS III = motor part of Unified Parkinson’s disease rating scale; LED =
Levedopa equivalent dose; tDCS = transcranial direct current stimulation; NR = not reported; M1 = primary motor cortex; PMC = pre-motor cortex; DLPFC =
Dorsolateral Prefrontal Cortex; TUG = Timed Up and Go Test; MMSE =Mini-Mental State Examination; PD-CRS = Parkinson’s Disease Cognitive Rating Scale; TMT =
Trial Making Test; HY = Hoehn and Yahr Scale; BDI-II = Beck Depression Inventory-II; PDQ-39 = Parkinson’s Disease Quality of Life Questionnaire-39; RBDSQ = REM
Sleep Behavior Disorders Screening Questionnaire; SICI = short intracortical inhibition; MEP =Motor evoked potential; ICF = Intracortical facilitation; UL-MT = upper
limb motor task; BBS = Berg Balance Scale; EEG = electroencephalography; DTC = dual-task cost; TMS = Transcranial magnetic stimulation; EMG = electromyography;
CSP = cortical silent period; RMT = resting motor threshold; STEF = simple test for evaluating hand function; FAB = Frontal Assessment Battery; BIS-11 = Barratt
Impulsivity Scale; IPNP = International Picture Naming Project
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• Adverse effects (occurrence)
Biundo (2015)
[33]
* Active tDCS reduced performance in the attention/executive skills and delayed memory index when compared to sham tDCS
at the post-test.
* Active tDCS tends to improve performance in the immediate memory index compared to the sham group at the follow-up test.




* Active tDCS decreased the episodes of freezing compared to sham tDCS.
* No effects of tDCS were found for the amplitude, variability, and speed of the strokes outside the freezing episodes.
* Patients who reported freezing episodes in daily life (n = 6) showed a beneficial effect of tDCS on stroke characteristics.
• No adverse events of tDCS were reported.
Broeder (2019)
[34]
* Active tDCS improved writing during the tDCS protocol, at the post-test and at follow-up compared to sham.
* Active tDCS increased writing amplitude at follow-up period compared to post period.
* Active tDCS enhanced cortical excitability compared to sham at the post-test.
* Active tDCS enhanced cortical excitability compared to sham at the post-test.
• No adverse events of tDCS were reported.
Costa-Ribeiro
(2016) [31]
* Both groups improved functional mobility either in on or off medication condition compared with baseline.
* However, for both medication conditions, these gains were maintained only in the tDCS+ gait training at follow-up test.
* In the tDCS + gait training, enhancement of cortical excitability was observed at post-intervention and 1-month follow-up




* Both groups improved functional mobility (velocity, cadence, and TUG), motor impairment, bradykinesia, balance, and quality of
life at post-test.
*For all outcome measures, no significant differences were found between groups.
* The improvement in velocity and TUG were maintained at the follow-up test only for patients in the Cueing gait training +
tDCS group.
• No adverse events were reported by any of the participants.
Criminger (2018)
[36]
*No differences were observed for TUG between conditions.
*Increased DTC in the TUG motor (gait) after a tDCSbike session when compared to tDCSwii.
*Increased DTC in the TUG cognitive (cognitive) after a tDCSbike session when compared to tDCSwii.
*Increased DTC in the TUG cognitive (gait) after a tDCSwii session when compared to tDCSbike.
• 1 participant was excluded from the initial sample (n = 18) after presenting headache in the first session.
Fernández-Lago
(2017) [37]
* All groups increased velocity, stride length, and short intracortical facilitation at post-test.
* All groups decreased Hmax/Mmax ratio and intracortical facilitation at post-test.




* Active tDCS + occupational therapy improved fatigue at post-test when compared to baseline.
• NR.
Horiba (2019) [39] * tDCS + mirror visual feedback increased the number of ball rotations at post-test.
* No significant changes on UPDRS-III motor section were observed.
• NR.
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• Adverse effects (occurrence)
Ishikuro (2018)
[40]
* Anodal tDCS decreased normalized scores of disease severity (UPDRS III) compared with Sham and Cathodal stimulation.
* Anodal stimulation improved executive function and increased normalized scores of sensory-motor functions compared with
Sham stimulation.
* Anodal stimulation increased normalized scores of STEF compared with Cathodal stimulation.
• 55.6% felt mild tingling. No adverse events were reported by any of the participants.
Kaski (2014) [25] * tDCS + physical training increased gait velocity and stride length when compared with tDCS.
* tDCS + physical training decreased the walking time and the time taken to regain stability following the retropulsion stimulus
when compared with tDCS.
* tDCS + physical training improved the turn phase of TUG.
* Sham + physical training decreased walking time and increased stride length but these were comparatively less than with
tDCS + physical training.
• NR.
Kaski (2014) [41] * Dance + tDCS increased peak trunk velocity in both pitch and roll directions.
* Dance + tDCS increased for the 90% velocity range and total trunk velocity area.




* Standard CT improved memory at follow-up test, quality of life, and activities of daily life at post-test. However, decreased
visuospatial ability at follow-up test.
* Tailored CT improved attention/working memory at follow-up and quality of life at post- and follow-up tests.
* tDCS improved attention/working memory at post- and follow-up tests, and memory at post-test.
* Standard CT + tDCS improved executive function and attention/working memory at post and follow-up tests, and language
and quality of life at post-test.
* Tailored CT + tDCS improved executive function, memory, and language at post- and follow-up tests, and attention/working
memory at the follow-up test.




* Both groups showed improvement in depression at post- and follow-up tests.
* Physical therapy + tDCS increased PD-CRS total, frontal-subcortical scores and verbal fluency at post, and stabilized the effect
at follow-up test.
* Physical therapy + tDCS group decreased the time necessary for completing TMT-B at post-test.
* Both groups improved the Standing Stork, Four Square Step, and Sit, and Reach Tests at post-test, with improvements
maintained at follow-up test for the Standing Stork, Four Square Step tests.




* Both groups improved language, attentional and executive functions at post and follow-up periods.
* Both groups increased phonemic fluency at post-test and semantic fluency at follow-up.
* tDCS + computerized cognitive training showed lower depressive symptoms and greater phonemic fluency when compared
to Sham + computerized cognitive training at post-test and follow-up.
• No adverse events were reported by any of the participants.
Schabrun (2016)
[44]
* Both groups improved gait velocity, cadence, step length and double support time in gait dual-tasks and bradykinesia at post-
and follow-up tests.
* Both groups improved functional mobility during TUG with words at post and follow-up tests.
* Active tDCS + dual-task gait training improved the number of correct responses during TUG with counting and TUG with words
at post-test, with a trend to maintain this performance in TUG with words at follow-up test.
* There were no differences between groups for reaction time and attention.
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(i.e. cross-over or parallel arms) and control (i.e. sham
tDCS). However, most included studies involved small
sample sizes (n < 24), which makes the results diffi-
cult to generalize to the full range of people with PD.
Also, tDCS protocols varied for stimulation time
(from 7.5 and 30 min) and number of sessions (from
1 to 16 sessions), making comparisons and definitive
conclusion regarding potential synergistic effects chal-
lenging. The most consistent synergistic effects were
reported for cognition [29, 33, 40, 42–44] and upper
limb function [28, 34, 39, 40]. Although findings re-
lated to other aspects of PD were inconsistent, syner-
gistic effects were also reported for gait and postural
control [25, 31, 35, 41]. The large heterogeneity in
stimulation parameters and combined interventions
may explain the large variation of findings that have
been reported by the reviewed studies. In addition, it
is not possible to determine if clinical and demo-
graphic characteristics of the studied individuals influ-
enced the observed variability on results.
Study types are chronic (C) or acute (A). * Others include Quality of Life, fatigue, sleep disorders.
Post Assessment Follow-up Assessment











































































































Biundo (2015) [33] C
Broeder (2019) [28] A
Broeder (2019) [34] A
Costa-Ribeiro (2016) [31] C
Costa-Ribeiro (2017) [35] C
Criminger (2018) [36] A
Fernández-Lago (2017) [37] A
Forogh (2017) [38] C
Horiba (2019) [39] A
Ishikuro (2018) [40] C
Kaski (2014) [25] A
Kaski (2014) [41] A
Lawrence (2018) [42] C
Manenti (2016) [29] C
Manenti (2018) [43] C
Schabrun (2016) [44] C
Yotnuengnit (2018) [45] C
Fig. 2 Synthesis of results in relation to the additional effect of tDCS. Green = Additional effect of combined intervention; Yellow = No additional
effect of the combined intervention; Red = Negative effect of the combined intervention; White = not assessed in the reviewed studies; A = Acute
(Considered the immediate effect of a single session); C = Chronic (Considered the effect of repeated sessions). * Others include Quality of Life,
fatigue, sleep disorders




• Adverse effects (occurrence)
• One participant experienced strong tingling over the site of one electrode and a momentary flash of light in his eyes. The
sensations lasted approximately 5 s. The participant ceased training that day but continued on subsequent days with no other
events, and no other symptoms.
Yotnuengnit
(2018) [45]
* All groups improved gait velocity and step time at post-test and at 2nd and 6th week follow-up.
* Physical therapy group increased cadence at 2nd and 6th week follow-up tests.
* tDCS and sham + physical therapy improved UPDRS II in all tests and the tDCS + physical therapy improved at the post and 2
weeks follow tests.
* All groups improved UPDRS III at post and 2nd week follow-up tests.
• Burning sensation (tDCS group).
PD = Parkinson’s disease; UPDRS III = motor part of Unified Parkinson’s disease rating scale; tDCS = transcranial direct current stimulation; NR = not reported; TUG =
Timed Up and Go Test; CT = cognitive training; CG = control group; PD-CRS = Parkinson’s Disease Cognitive Rating Scale; TMT = Trail Making Test; DTC = dual-task
cost; Hmax =maximum H-reflex amplitude; Mmax =maximum M amplitude; STEF = simple test for evaluating hand function; * indicate the main results; • indicate
the adverse effects (occurrence)
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Methodological aspects
The included studies were consistent with regards to
tDCS polarity and site of stimulation. In all studies, the
anode electrode was placed in order to target brain area
related to motor or cognitive functions. Studies aiming
to improve cognition targeted DLPFC while those aim-
ing to improve motor aspects of PD targeted M1, SMA
and/or PMC. As PD is characterized by reduced dopa-
minergic signaling by the substantia nigra pars compacta
and the consequent increased GABAergic signaling from
the basal ganglia to other encephalic regions, it makes
sense to use anodal tDCS for rehabilitation in PD. An-
odal tDCS has been shown to increase extracellular
dopamine levels in the striatum [21] and inhibit
GABAergic neurons [22, 23]. However, it is somewhat
surprising that only one of the reviewed studies used
cathodal tDCS [40]. Ishikuro et al. [40] applied the cath-
odal tDCS over the occipital area. A growing body of
evidence supports the hypothesis that the functional in-
terhemispheric imbalance contributes to the clinical
motor deficits in PD. For example, PD is associated with
asymmetry in M1 excitability [47, 48], with the more-
affected hemisphere showing decreased excitability in
comparison to the less-affected one. Thus, cathodal
tDCS applied to the less-affected hemisphere (as well as
anodal tDCS on the more-affected hemisphere) may also
benefit patients with PD by leading to a more balanced
interhemispheric activity. Cosentino et al. (2017) [49]
observed that anodal tDCS of the more-affected M1 and
cathodal tDCS of the less-affected M1 were able to in-
duce polarity-specific changes in cortical excitability,
leading to a more balanced interhemispheric excitability.
These authors also observed that motor performances of
both hands improved after both stimulation protocols
[49]. Additional studies investigating the effects of cath-
odal tDCS in PD is required, especially when applied in
combination with physical or cognitive interventions.
Another consistent aspect of the intervention proto-
cols of the reviewed studies refers to current intensity.
Thirteen studies used 2mA and none compared the
effects of different tDCS intensities when applied in
combination with other interventions. The choice for 2
mA may be justified by the fact that some neurophysio-
logical studies have shown greater increase in cortical
excitability after 2 mA tDCS when compared to 1 mA
[50, 51]. Also, longer lasting effects have been associated
with greater current intensities [15]. However, other
studies have found no differences in cortical excitability
when comparing 2 mA and 1mA [52–54]. Further re-
search is required to understand if current intensity is a
moderator factor when tDCS is applied in combination
with other complementary interventions. Tolerability and
safety of current intensities greater than 2mA are still to
be investigated in this kind of interventions in PD.
Reported findings
Consistent synergistic effects were reported for cognition
when tDCS was applied in combination with other mo-
dalities of complementary interventions. All six studies
reporting synergistic effects on cognition used multiple
sessions (4 to 16 sessions). Current intensity included
1.0, 1.5 or 2.0 mA. The reported synergistic effects were
consistent with the area targeted by tDCS. Four studies
targeted the DLPFC and one study target the frontal
polar area, cortical regions known to be involved in ex-
ecutive function and working memory [29, 33, 42]. Inter-
estingly, one study that stimulated M1 observed
increased number of correct responses provided while
performing the TUG test under dual-task condition (i.e.,
concomitant cognitive task) [44]. Authors argued that
individuals with PD improved their ability to dual task
when walking due to improved movement automaticity
after the intervention. It is possible that anodal tDCS on
M1 improved the efficiency of the direct locomotor
pathway (i.e. neuronal commands are transmitted dir-
ectly from M1 to the spinal cord), leading to a more
automatic control [55, 56]. Then, the attentional and ex-
ecutive resources previously required for the control of
movements could be reallocated to the performance of
the concomitant cognitive task, which led to better per-
formance of such task.
Upper limb function and motor symptoms (as assessed
by UPDRS-III) respond differently to combined inter-
ventions involving tDCS. Consistent synergistic effects
were reported for upper limb function [28, 34, 39, 40].
Since methods of the studies reporting the synergistic ef-
fects on upper limb function varied, it is difficult to es-
tablish associations with results. Overall, synergistic
effects were observed after a single or multiple sessions,
with tDCS targeting DLPFC or M1. On the other hand,
motor symptoms as assessed by UPDRS-III seem to not
benefit from the addition of tDCS on physical/cognitive
interventions. Only one (out of five) study observed syn-
ergistic effects on motor symptoms [40]. UPDRS-III may
miss subtle motor improvements and, therefore, we sug-
gest future studies to use more objective assessments of
clinical motor symptoms (e.g., inertial sensors, electro-
myography, etc.).
Although inconsistent, synergistic effects were also re-
ported for gait and mobility when tDCS was combined
with other complementary interventions in people with
PD. Two out of eight studies reported synergistic effects
of tDCS on gait and mobility at post-test [25, 41]. These
two studies involved immediate physical interventions
(i.e. gait training and tango dance) with stimulation tar-
geting bilateral M1 and PMC. Studies targeting one cor-
tical area (i.e. unilateral M1 or prefrontal cortex - PFC)
observed similar results for both active and sham tDCS.
Given the multiple cortical regions involved in gait and
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the bilateral representation of these regions [55, 57], it is
possible that bilateral stimulation of multiple cortical
areas is required to provide synergistic immediate effects
(i.e. at post-test) to gait in people with PD. Also, two
studies observed synergistic effects on gait and mobility
at follow-up assessment [31, 35]. Costa-Ribeiro et al. [31,
35] observed that tDCS (applied before the physical
intervention) prolonged the effects of cued gait training
on functional mobility and that this benefit is independ-
ent of dopaminergic medication. The synergistic effects
on mobility at follow-up assessment could be explained
by the changes in cortical excitability. While both sham
and active tDCS groups increased cortical excitability
and improved mobility at post assessment, only the gait
training plus active tDCS group maintained the benefits
at the follow-up assessment [31]. Thus, there seems to
be a positive relationship between increased cortical ex-
citability and improvement in mobility in patients with
PD [11, 31].
Synergistic effects on postural control were also
reported when tDCS was combined with physical inter-
ventions in people with PD. Four studies assessed
postural control, but only two studies presented syner-
gistic effects of active tDCS combined with gait training
and tango dance [25, 41]. These studies involved a single
session of intervention and stimulated motor areas (i.e.
M1 and PMC) bilaterally. The other two studies that re-
ported no synergistic effects at the post and follow-up
assessments involved 10 sessions of physical interven-
tions (i.e. physical therapy and cued gait training) and
stimulated M1 and PFC unilaterally (contralateral to the
most affected body side). Postural control involves sev-
eral cortical areas (i.e. PFC, PMC, SMA, M1, and pri-
mary sensory cortex – S1) in both hemispheres and the
cerebellum [2, 58]. Therefore, it is possible that bilateral
stimulation of multiple areas is necessary for the syner-
gistic immediate effects to postural control in patients
with PD. Besides, it should be noted that the synergistic
effects were evidenced by studies that performed the
stimulation during the physical intervention. Physical
training has been shown to normalize M1 excitability in
people with PD [59], while tDCS may decrease the
threshold for these changes to occur, facilitating long-
lasting effects [11, 25].
Limitations apply while interpreting the current find-
ings. This review is limited by the small number of
papers identified (n = 17) in the literature and the varied
protocols tested in the included studies. This limits our
interpretations and makes definitive conclusion regard-
ing potential synergistic effects challenging. Additionally,
although we acknowledge the contributions of open-
label studies to the developments in this emerging area
of research, we opted to exclude open-label studies from
our review due to the inherent methodological flaws of
such design. Despite these limitations, this review
provides a useful synthesis of the existing studies on the
combination of tDCS with physical/cognitive interven-
tions in PD, which may guide the development of the
field towards a more robust body of evidence.
Conclusions
Although the reviewed studies used appropriate design
and control, they involved a limited number of partici-
pants, which may imply underpowered analysis. Thus,
large-scale studies are needed. Despite this major flaw,
the reported results of tDCS interventions combined
with cognitive and/or motor interventions encourage
further research to better understand its therapeutic
utility and to inform optimal clinical use in PD. The
reviewed studies suggest that synergistic effects may be
obtained for cognition, upper limb function gait/mobility
and posture when tDCS is combined with cognitive and/
or motor interventions in PD. Future studies in this field
should focus on determining optimal stimulation param-
eters and intervention characteristics for maximal bene-
fits in people with PD. Research on identifying potential
predictors of response to tDCS-based interventions (i.e.
tDCS combined with cognitive and/or motor interven-
tions) in people with PD should also be conducted.
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